findmyKOL
Clinical trialNCT06660355RecruitingPhase 2Interventional

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

SponsorH. Lee Moffitt Cancer Center and Research InstituteEnrollment120Chronic Graft-versus-host Disease (cGVHD)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Univ of Miami - Sylvester Comprehensive Cancer Center

    Miami, Florida, United States

    Noa Holtzman, MD
    Recruiting
  • Moffitt Cancer Center

    Tampa, Florida, United States

    Aleksandr Lazaryan, MD, PhDAsmita Mishra, MDCiara Freeman, MD, PhDDoris Hansen, MDFabiana Perna, MD, PhDFarhad Khimani, MDFrederick Locke, MDHany Elmariah, MDHien Liu, MDJose Ochoa-Bayona, MDJoseph Pidala, MD, PhDLia Perez, MDMelissa Alsina, MDMichael Jain, MD, PhDNelli Bejanyan, MDOmar Castaneda Puglianini, MDRawan Faramand, MDSayeef Mirza, MDTaiga Nishihori, MD
    Recruiting
  • University of Kansas Cancer Center

    Kansas City, Kansas, United States

    Muhammad Umair Mushtaq, MD
    Recruiting
  • University of Virginia Comprehensive Cancer Center

    Charlottesville, Virginia, United States

    Indumathy Varadarajan, MD
    Recruiting
  • Virginia Commonwealth University

    Richmond, Virginia, United States

    William Clark, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Dec 2024
Primary completion
31 Dec 2028
Completion
31 Dec 2028
Last update posted
8 Apr 2026
Registered enrollment
120
Registry id
NCT06660355
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.